Phylicia Aaron
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
Papers in
- Oncology 12
- PARP inhibition in cancer therapy 8
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
-
- Ovarian cancer diagnosis and treatment 7
- Co-authors
- Angie Gelli (4 shared papers)John Nemunaitis (15 shared papers)Luisa Manning (13 shared papers)Laura Stanbery (11 shared papers)Mantana Jamklang (1 shared paper)Ernest Bognar (13 shared papers)Gladice Wallraven (6 shared papers)Staci Horvath (7 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Gynecologic Oncology (3 papers)Cancer Gene Therapy (2 papers)mBio (1 paper)Vaccines (1 paper)
- Partner nations
- United StatesQatar
In The Last Decade
Phylicia Aaron
20 papers receiving 278 citations
Peers
Comparison fields: 5 of 60
- Reproductive Medicine 66
- Oncology 159
- Immunology 104
- Microbiology 2
- Infectious Diseases 44
Countries citing papers authored by Phylicia Aaron
This map shows the geographic impact of Phylicia Aaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phylicia Aaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phylicia Aaron more than expected).
Fields of papers citing papers by Phylicia Aaron
This network shows the impact of papers produced by Phylicia Aaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phylicia Aaron. The network helps show where Phylicia Aaron may publish in the future.
Co-authors
The 25 scholars most cited alongside Phylicia Aaron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 51 | |
| 2 | 2020 | 47 | |
| 3 | 2021 | 26 | |
| 4 | 2021 | 20 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 18 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 14 | |
| 9 | 2020 | 14 | |
| 10 | 2021 | 12 | |
| 11 | 2019 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2018 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 3 | |
| 19 | A case of Fabry disease (alpha-galactosidase A deficiency). | 1994 | 1 |
| 20 | 2020 | 1 |
About Phylicia Aaron
Phylicia Aaron is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Immunology and Genetics, having authored 20 papers that have together received 285 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), Ovarian cancer diagnosis and treatment (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Research and Treatments (4 papers), Virus-based gene therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Reproductive Medicine (66 citations), Oncology (159 citations), Immunology (104 citations), Microbiology (2 citations) and Infectious Diseases (44 citations). Phylicia Aaron has collaborated with scholars based in United States and Qatar. Frequent co-authors include Angie Gelli, John Nemunaitis, Luisa Manning, Laura Stanbery, Mantana Jamklang, Ernest Bognar, Gladice Wallraven, Staci Horvath, Rodney P. Rocconi and Kiem Vu. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Cancer Gene Therapy, mBio and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.